News | July 22, 2014

Seven presentations at the 2014 American Association of Physicists in Medicine (AAPM) meeting focus on early adopters' work with Varian's Edge radiosurgery


July 22, 2014 — Medical researchers have confirmed the Edge radiosurgery system from Varian Medical Systems can deliver dose to a targeted tumor with sub-millimeter isocenter accuracy.  The researchers, from the Champalimaud Centre for the Unknown in Lisbon, Portugal, and other teams from the Henry Ford Health System in Detroit, Michigan, made seven scientific presentations about the Edge system during the 2014 American Association of Physicists in Medicine (AAPM) meeting from July 20-24. 

The Champalimaud team worked with scientists from Varian to conduct "end-to-end" testing of the Edge system, to demonstrate its diverse subsystems can work together to yield sub-millimeter accuracy when delivering dose.

Investigators from the Henry Ford Health System did early work with the Edge radiosurgery system covering a wide spectrum of clinical issues, from the accuracy of patient setup for image-guided intracranial (brain) radiosurgery to methods for accurately commissioning a new Edge system. One of the Henry Ford teams presented preliminary data on the accuracy of dose calculations for treating small, elongated tumors with radiosurgery. 

The Edge radiosurgery suite combines Varian's world-class technologies in an end-to-end solution for planning and delivering radiosurgery treatments. It integrates Varian's most advanced medical linear accelerator — a machine that produces the high energy X-ray beams used to treat disease — with tools for real-time imaging, tumor tracking, motion management and patient positioning. The Edge enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine and brain.

For more information: www.varian.com


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now